Publications by authors named "Jeff Botbyl"

Claim this Profile
E
Effect of lapatinib on oral digoxin absorption in patients.
Kevin M Koch, Deborah A Smith, Jeff Botbyl, Nikita Arya, Linda P Briley

Clin Pharmacol Drug Dev· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of the drug interaction potential and single- and repeat-dose pharmacokinetics of the BRAF inhibitor dabrafenib.
A Benjamin Suttle, Kenneth F Grossmann, Daniele Ouellet, Lauren E Richards-Peterson, Gursel Aktan, Jeff Botbyl

J Clin Pharmacol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I open-label study of the safety, tolerability, and pharmacokinetics of pazopanib in combination with irinotecan and cetuximab for relapsed or refractory metastatic colorectal cancer.
Jaafar Bennouna, Marion Deslandres, Helene Senellart, Cecile de Labareyre, Rodrigo Ruiz-Soto, Jeff Botbyl

Invest New Drugs· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of low-fat and high-fat meals on steady-state pharmacokinetics of lapatinib in patients with advanced solid tumours.
Lot A Devriese, Kevin M Koch, Marja Mergui-Roelvink, Gemma M Matthys, Wen Wee Ma, Jeff Botbyl

Invest New Drugs· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis